ATE174928T1 - Peptidzusammensetzung von exoenzym s von pseudomonas und verfahren zu deren erstellung - Google Patents

Peptidzusammensetzung von exoenzym s von pseudomonas und verfahren zu deren erstellung

Info

Publication number
ATE174928T1
ATE174928T1 AT92912325T AT92912325T ATE174928T1 AT E174928 T1 ATE174928 T1 AT E174928T1 AT 92912325 T AT92912325 T AT 92912325T AT 92912325 T AT92912325 T AT 92912325T AT E174928 T1 ATE174928 T1 AT E174928T1
Authority
AT
Austria
Prior art keywords
peptide
pseudomonas aeruginosa
exoenzyme
reactive
cross
Prior art date
Application number
AT92912325T
Other languages
English (en)
Inventor
Robert S Hodges
Randall T Irvin
William Paranchych
Pamela A Sokol
Donald E Woods
Original Assignee
Synthetic Peptides Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthetic Peptides Inc filed Critical Synthetic Peptides Inc
Application granted granted Critical
Publication of ATE174928T1 publication Critical patent/ATE174928T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92912325T 1991-06-25 1992-06-23 Peptidzusammensetzung von exoenzym s von pseudomonas und verfahren zu deren erstellung ATE174928T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/721,759 US5223604A (en) 1991-06-25 1991-06-25 Pseudomonas exoenzyme s peptide composition and method

Publications (1)

Publication Number Publication Date
ATE174928T1 true ATE174928T1 (de) 1999-01-15

Family

ID=24899196

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92912325T ATE174928T1 (de) 1991-06-25 1992-06-23 Peptidzusammensetzung von exoenzym s von pseudomonas und verfahren zu deren erstellung

Country Status (6)

Country Link
US (2) US5223604A (de)
EP (1) EP0592470B1 (de)
AT (1) ATE174928T1 (de)
AU (1) AU1974992A (de)
DE (1) DE69227994T2 (de)
WO (1) WO1993000358A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826116D0 (en) * 1988-11-08 1988-12-14 Danbiosyst Ltd Adhesive drug delivery composition
US5494672A (en) * 1989-04-28 1996-02-27 S.P.I. Synthetic Peptides Incorporated Pseudomonas peptide composition and method
WO1994008617A1 (en) * 1992-10-16 1994-04-28 Brigham And Women's Hospital, Inc. O-derivatized alginic acid antigens
US6872542B1 (en) * 1993-11-18 2005-03-29 Siga Pharmaceuticals, Inc. Treatment or prophylaxis of diseases caused by pilus-forming bacteria
US5599665A (en) * 1993-12-21 1997-02-04 Mcw Research Foundation Pseudomonas aeruginosa nucleic acids encoding exoenzyme S activity and use thereof in detecting pseudomonas aeruginosa infection
JPH07219339A (ja) * 1994-01-31 1995-08-18 Canon Inc 弾性ブレード及びその製造方法及び現像装置
US6872398B2 (en) * 1995-12-22 2005-03-29 The United States Of America As Represented By The Secretary Of The Army Conjugate vaccine against gram-negative bacterial infections
US6166176A (en) * 1998-03-17 2000-12-26 Immvarx, Inc. Cancer marker protein and peptides thereof
JP2002513802A (ja) * 1998-05-06 2002-05-14 ザ ガバナーズ オブ ザ ユニバーシティー オブ アルバータ Ｐｓｅｕｄｏｍｏｎａｓａｅｒｕｇｉｎｏｓａのためのワクチン
CA2329689A1 (en) * 1998-06-12 1999-12-23 The Governors Of The University Of Alberta Composition and method for treatment of pseudomonas
US6495442B1 (en) * 2000-10-18 2002-12-17 Magic Corporation Post passivation interconnection schemes on top of the IC chips
US20030228324A1 (en) * 1999-05-06 2003-12-11 Malcolm Andrew J. Peptide compositions and methods of producing and using same
US6187822B1 (en) * 1999-06-11 2001-02-13 University Of Medicine & Dentistry Of Nj Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
US20020188489A1 (en) * 2001-05-22 2002-12-12 International Business Machines Corporation System and method for optimizing office worker productivity
DE10294091D2 (de) * 2001-09-13 2004-08-05 Hannover Med Hochschule Phänotyp bestimmende Virulenzgene von Pseudomonas aeruginosa zur Kolonisation und Persistenz in Mensch, Tier und Pflanze, Verwendungen der Gene und zugehörigen Proteine
AU2005294436A1 (en) * 2004-10-04 2006-04-20 Trinity Biosystems, Inc. Methods and compositions for immunizing against Pseudomonas infection
EP1919494A4 (de) 2005-07-22 2011-11-09 Univ Colorado Regents Nichttoxischer biofolien-hemmer
CN110922454B (zh) * 2019-12-05 2020-11-06 中国科学院深圳先进技术研究院 绿脓杆菌毒素ExoS和ExoT的免疫用途及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892827A (en) * 1986-09-24 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects
CA1340530C (en) * 1989-04-28 1999-05-04 Kok Kheong Lee Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics

Also Published As

Publication number Publication date
WO1993000358A1 (en) 1993-01-07
US5223604A (en) 1993-06-29
DE69227994T2 (de) 1999-08-26
EP0592470A1 (de) 1994-04-20
US5468484A (en) 1995-11-21
DE69227994D1 (de) 1999-02-04
EP0592470B1 (de) 1998-12-23
AU1974992A (en) 1993-01-25

Similar Documents

Publication Publication Date Title
DE69227994D1 (de) Peptidzusammensetzung von exoenzym s von pseudomonas und verfahren zu deren erstellung
CA2103887A1 (en) Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
AR001731A1 (es) Nueva celulasa método para producirla composición que la contiene vector que comprende al adn que lacodifica celula huesped método de aplicación
CA2340304A1 (en) Multicomponent vaccines
AU6033299A (en) Compositions of beta-glucans and specific igiv
NO20003716D0 (no) Protein D for anvendelse in vitro, renset antistoff som binder proteinet, samt anvendelser derav
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
ATE168131T1 (de) T-cadherin-bindungsmolekül
EP0672063A1 (de) Kleinste erkennungseinheit eines pem-mucin-"tandem repeat"-spezifischen monoklonalen antikoerpers.
ATE235916T1 (de) Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern
WO2003085085A3 (en) Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
DE69322092D1 (de) Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
ATE184612T1 (de) Peptidzusammensetzung aus pseudomonas und methode diese herzustellen
Hastings et al. The humoral immune response of rainbow trout, Salmo gairdneri Richardson, and rabbits to Aeromonas salmonicida extracellular products
CA2217522A1 (en) Isolated frpb nucleic acid molecule and vaccine
ATE121754T1 (de) Vakzine gegen bordetella.
MD960242A (en) Microorganisms for biological control of plants diseases
WO2001040280A3 (en) Composition and method for treating a microbial infection
ATE427320T1 (de) Behandlung von infektionen verursacht von mikroorganismen
WO2002094190A3 (en) Heterologous protection induced by immunization with invaplex vaccine
DE69332471D1 (de) Verfahren zur herstellung modifizierten proteine
ATE420951T1 (de) Schützende epitope von adenylate-zyklase- hämolysin(ac-hly) und ihre verwendung zur behandlung oder verhütung von bordetella- infektionen
Pagliaccia et al. Pertactin antigens extracted from Bordetella pertussis and Bordetella bronchiseptica differ in the isoelectric point
AU8501191A (en) Cross-reactive influenza a immunization
AU6306390A (en) Antibodies against highly conserved amino acid sequences of immunogenic substances, a process for the preparation of these antibodies and the use thereof in immunoassays

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties